Alyaa Al-Ibraheemi

Alyaa Al-Ibraheemi

Auto-generated profile, based on publicly available information

Alyaa Al-Ibraheemi

Department of Pathology, Boston Children's Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2023 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
ICIsidro Cortes-Ciriano
Isidro Cortes-Ciriano
CSChristopher D. Steele
Christopher D. Steele
KPKatherine Piculell
Katherine Piculell
AAAlyaa Al-Ibraheemi
Alyaa Al-Ibraheemi
VEVanessa Eulo
Vanessa Eulo
DMDavid Miller
David Miller
Malignant peripheral nerve sheath tumor (MPNST), an aggressive soft-tissue sarcoma, occurs in people with neurofibromatosis type 1 (NF1) and sporadically. Whole-genome and multiregional exome sequencing, transcriptomic, and methylation profiling of 95 tumor samples revealed the order of genomic events in tumor evolution. Following biallelic inactivation of NF1, loss of CDKN2A or TP53 with or without inactivation of polycomb repressive complex 2 (PRC2) leads to extensive somatic copy-number aberrations (SCNA). Distinct pathways of tumor evolution are associated with inactivation of PRC2 genes and H3K27 trimethylation (H3K27me3) status. Tumors with H3K27me3 loss evolve through extensive chromosomal losses followed by whole-genome doubling and chromosome 8 amplification, and show lower levels of immune cell infiltration. Retention of H3K27me3 leads to extensive genomic instability, but an immune cell-rich phenotype. Specific SCNAs detected in both tumor samples and cell-free DNA (cfDNA) act as a surrogate for H3K27me3 loss and immune infiltration, and predict prognosis. Significance: MPNST is the most common cause of death and morbidity for individuals with NF1, a relatively common tumor predisposition syndrome. Our results suggest that somatic copy-number and methylation profiling of tumor or cfDNA could serve as a biomarker for early diagnosis and to stratify patients into prognostic and treatment-related subgroups. This article is highlighted in the In This Issue feature, p. 517

27 December 2021 in Histopathology
Verified
Journal Article
Closed access
PDF file
JDJessica L Davis
Jessica L Davis
AAAlyaa Al‐Ibraheemi
Alyaa Al‐Ibraheemi
ERErin R Rudzinski
Erin R Rudzinski
LSLea F Surrey
Lea F Surrey

28 January 2020 in Histopathology
Verified
Journal Article
Closed access
PDF file
JDJessica L. Davis
Jessica L. Davis
SVSara O Vargas
Sara O Vargas
ERErin R Rudzinski
Erin R Rudzinski
JMJessica M López Marti
Jessica M López Marti
KJKatherine Janeway
Katherine Janeway
AAAlyaa Al‐Ibraheemi
Alyaa Al‐Ibraheemi

6 December 2018 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
AAAlyaa Al-Ibraheemi
Alyaa Al-Ibraheemi
CBCory Broehm
Cory Broehm
MTMunir R. Tanas
Munir R. Tanas
AHAndrew E. Horvai
Andrew E. Horvai
BRBrian P. Rubin
Brian P. Rubin
KFKaren J. Fritchie
Karen J. Fritchie
Objectives. Desmoplastic small round cell tumor (DSRCT) is an aggressive round cell sarcoma that arises in the abdominal cavity/pelvis of young males. We sought to expand its clinicopathologic spectrum. Methods. Cases of DSRCT presenting in patients >30 years of age or tumors arising outside of the abdominal cavity/pelvis were retrieved. Results. Thirty-four cases were identified. Sixteen tumors arose at atypical sites (head/neck, intracranial, thigh, axilla/shoulder, inguinal/paratesticular, intraosseous, and uterine corpus). The remaining 18 patients were older than 30 years, and their tumors involved the abdomen or pelvis. The majority of cases showed areas with classic histology, while 6 cases exhibited solid growth and 5 showed macronodular architecture. Cytologic appearance included round cell, rhabdoid, epithelioid, and small cell. Conclusion. DSRCT may arise at nonabdominal locations in both pediatric and adult populations, as well as intra-abdominally in older adults, and these tumors exhibit high rates of metastasis and morbidity.

1 March 2019 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
JPJuan Putra
Juan Putra
AAAlyaa Al-Ibraheemi
Alyaa Al-Ibraheemi

2 April 2020 in Genes
Verified
Journal Article
Open access
PDF file
DMDavid Miller
David Miller
ICIsidro Cortés-Ciriano
Isidro Cortés-Ciriano
NPNischalan Pillay
Nischalan Pillay
Angela HirbeAngela Hirbe
Angela Hirbe
MSMatija Snuderl
Matija Snuderl
AFAdrienne M. Flanagan
Adrienne M. Flanagan
The Genomics of Malignant Peripheral Nerve Sheath Tumor (GeM) Consortium is an international collaboration focusing on multi-omic analysis of malignant peripheral nerve sheath tumors (MPNSTs), the most aggressive tumor associated with neurofibromatosis type 1 (NF1). Here we present a summary of current knowledge gaps, a description of our consortium and the cohort we have assembled, and an overview of our plans for multi-omic analysis of these tumors. We propose that our analysis will lead to a better understanding of the order and timing of genetic events related to MPNST initiation and progression. Our ten institutions have assembled 96 fresh frozen NF1-related (63%) and sporadic MPNST specimens from 86 subjects with corresponding clinical and pathological data. Clinical data have been collected as part of the International MPNST Registry. We will characterize these tumors with bulk whole genome sequencing, RNAseq, and DNA methylation profiling. In addition, we will perform multiregional analysis and temporal sampling, with the same methodologies, on a subset of nine subjects with NF1-related MPNSTs to assess tumor heterogeneity and cancer evolution. Subsequent multi-omic analyses of additional archival specimens will include deep exome sequencing (500×) and high density copy number arrays for both validation of results based on fresh frozen tumors, and to assess further tumor heterogeneity and evolution. Digital pathology images are being collected in a cloud-based platform for consensus review. The result of these efforts will be the largest MPNST multi-omic dataset with correlated clinical and pathological information ever assembled.